A recent report from the Lancet Commission sheds light on the global imbalance in power dynamics that has negatively affected women’s access to cancer prevention, detection, and care. Despite significant advancements in healthcare, cancer remains one of the leading causes of premature death among women worldwide. Each year, an alarming 2.3 million women die prematurely from cancer, with 1.5 million of those deaths being preventable through the elimination of key risk factors and early detection. The report identifies gender inequalities and discrimination as major barriers to women’s ability to avoid cancer risk factors and gain timely access to quality care. To address these issues, the report calls for a “new feminist agenda” to eliminate gender inequality in oncology.
The Lancet Commission report highlights the largely unrecognized impact of patriarchal society on women’s experiences with cancer. Co-Chair of the Commission, Ophira Ginsburg, emphasizes the need to prioritize cancer as a women’s health issue and advocates for the immediate integration of a feminist approach to cancer care. The report points out that gender inequalities and discrimination extend beyond “women’s cancers” and affect various types of cancer, such as lung and colorectal cancer. In fact, lung cancer has become a leading cause of cancer death among women in many high-income countries, surpassing breast cancer. The tobacco and alcohol industries specifically target women, necessitating government intervention to counteract these actions through gender-specific policies aimed at increasing awareness and reducing exposure to these risk factors.
The Lancet Commission report not only presents staggering figures related to cancer mortality but also identifies key findings and priorities for action. Some of the key findings include the dominance of patriarchal structures in cancer care, research, and policy, and the underrepresentation of women in healthcare leadership positions. Furthermore, women in the cancer workforce often face severe gender-based discrimination. The report emphasizes the need to collect comprehensive data on cancer statistics, develop transformative strategies to enhance access to early detection and diagnosis, and create accessible and responsive health systems that provide quality care for women and girls. It also calls for equitable access to cancer research resources, leadership, and funding, as well as the development and enforcement of gender-based harassment and discrimination policies in the cancer workforce.
Applicability to Developed Nations
While the report’s relevance may seem primarily focused on developing and underdeveloped countries, its findings are highly applicable to developed nations, including the United States. Chief Medical Officer for the American Society of Clinical Oncology, Julie Gralow, emphasizes how the report highlights the wide-ranging impact of cancer diagnoses on women, families, and society as a whole. Additionally, the report addresses the role of women not only as patients but also as caregivers, decision-makers, healthcare professionals, and researchers in the cancer field. The report underscores the need to recognize and address gender inequality’s impact on cancer prevention, early detection, treatment, and outcomes.
Closing the Gender Gap
The commission’s key findings collectively emphasize the importance of closing the gender gap in terms of resources and support for those affected by cancer. The report recognizes the intersectionality of various factors, such as finances, geography, socioeconomic status, culture, and religion, that influence women’s health outcomes. By implementing the recommended action points, communities and individuals can make a significant difference in addressing these disparities on a local and global scale. While the report may elicit diverse reactions and responses, it is crucial to recognize that addressing gender inequality in cancer care is essential for improving women’s health and overall healthcare outcomes.
The Lancet Commission’s report sheds light on the global imbalance that negatively impacts women’s access to cancer prevention, detection, and care. Gender inequalities and discrimination significantly impede women’s ability to avoid cancer risk factors and gain timely access to quality care. The report calls for a transformative approach encompassing data collection, policy changes, improved access to care, and gender equity in research and healthcare leadership. These recommendations are not only relevant to developing nations but also applicable to developed countries, highlighting the need for a comprehensive feminist agenda to address gender inequality in the realm of cancer care. By closing the gender gap and empowering women in cancer prevention and treatment, we can strive towards a more equitable and effective healthcare system for all.